Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Oct 2017 for Hemogenyx Pharmaceuticals PLC, €5,440.
Filing timeline
BuySalePeter Redmond
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter Redmond: trading record in brief
Our data holds just one disclosure by Peter Redmond, dated 10 October 2017, reporting an open-market purchase worth €5,440 in Hemogenyx Pharmaceuticals PLC. Further filings will be added here. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Peter Redmond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 155,000 shares@ £0.0314100.0% of flowLondon Stock ExchangeISIN GB00BYX3WZ24FCA-NSM:LSE20171010070004_13391128_20200330131537618_6138-1Canonical exit: 4 Jan 2018 (T+90)
1 of 1 declaration